French group Eurofins targets more COVID-19 products as H1 profits rise

PARIS, Aug 6 (Reuters) - French laboratories and diagnostics company Eurofins EUFI.PA said it hoped to launch more products aimed at detecting the presence of the COVID-19 virus, as it posted higher first-half profits.

Net profits rose 60.9% from a year earlier to 95 million euros ($113 million). Revenues increased 7.2% to 2.323 billion euros and Eurofins said it was confident of meeting its 2020 financial targets, which include reaching 5 billion euros of revenues.

Eurofins has launched an array of products to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease.

($1 = 0.8415 euros)

(Reporting by Sudip Kar-Gupta Editing by Shri Navaratnam)

((; +33 1 49 49 53 84;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.